61
Views
25
CrossRef citations to date
0
Altmetric
Review

A return to rational drug discovery: computer-based models of cells, organs and systems in drug target identification

&
Pages 39-49 | Published online: 25 Feb 2005

Bibliography

  • BRENNER S: Biological Computation. In The Limits of Reductionism in Biology. GR Bock, JA Goode (Eds.), Novartis Foundation Symposium, John Wiley (1998) 213:106–116.
  • CH'EN FT, VAUGHAN-JONES RD, CLARKE K, NOBLE D: Modelling myocardial ischaemia and rep erfusion. Progr. Biophys. Mol Biol. (1998) 69:515–537.
  • ••Reconstruction of arrhythmic mechanisms resulting fromsodium-calcium overload during cardiac ischaemia and reperfusion.
  • RUBEN PC, VILIN YY, FUJIMOTO E: Molecular basis of slow inactivation in sodium channels. J. Physiol. (2000) Proceedings of Pucón Meeting (In Press)
  • NOBLE D, NOBLE PJ: Reconstruction of cellular mechanisms of genetically-based arrhythmias. j of Physiol. (1999) 518:2–3P.
  • •Modelling of genetic basis of arrhythmias.
  • CLANCY CE, RUDY Y: linking a genetic defect to its cellular phenotype in a cardiac arrhythmia. Nature (1999) 400:566–569.
  • •Modelling of genetic basis of arrhythmias
  • NOBLE D, LEVIN J, SCOTT W: Biological simulations in drug discovery. Drug Disc. Today (1999) 4:10–16.
  • KOHL P, NOBLE D, WINSLOW RL, HUNTER P: Computa-tional modelling of biological systems: tools and visions. Phil. Trans. R. Soc. fond. (2000) 358:579–610.
  • BAILEY JE: lessons from metabolic engineering for functional genomics and drug discovery. Nature Biotech. (1999) 17:616–618.
  • ••Review of arguments for multiple target strategy.
  • BRIL A, GOUT B, BONHOMME M et al.: Combined potassium and calcium channel blocking activities as a basis for antiarrhythmic efficacy with low proarrhythmic risk: experimental profile of BRL-32872. j Pharmacol Exp. Ther. (1996) 276 :637–646.
  • •Example of multiple-target drug development.
  • NADLER G, FAIVRE JF, FOREST MC et al.: Synthesis, electrophysiological properties and analysis of structural requirements of a novel class of antiar-rhythmic agents with potassium and calcium channel blocking properties. Bioorg. Med. Chem. (1998) 6:1993–2011.
  • WINSLOW RL, RICE J, JAFRI S: Modeling the cellular basis of altered excitation-contraction coupling in heart failure. Prog. Biophy. Mol. Biol. (1998) 69:497–514.
  • ••Reconstruction of the cellular basis of electrophysiologicalchanges in congestive heart failure based on changes in expression levels of the transporters involved.
  • KIMURA J, WATANO T, KAWAHARA M, SAKAI E, YATABE J: Direction-independent block of bi-directional Na-Ca exchange current by KB-R7943 in guinea-pig cardiac myocytes. Br. J. Pharmacol. (1999) 128:969–974.
  • CRUMB W, CAVERO I: QT interval prolongation by non-cardiovascular drugs: issues and solutions for novel drug development. Pharm. Sci. Technol. Today (1999) 2(7):270–280.
  • MUZIKANT AL, RICE JJ, CHEN G, COLATSKY TJ: Simula-tion of transmural ECGs for drug safety screening using a computer-based left ventricular wedge model. Annual General Safety Pharmacology Meeting Philadel-phia, PA, USA (October 1999).
  • ••First modelling of ECG based on incorporation of cellularmodels into 3D structures.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.